{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:43:14Z","timestamp":1784191394213,"version":"3.55.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T00:00:00Z","timestamp":1356480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Because of the low prevalence of onychomycosis in children, little is known about the efficacy and safety of systemic antifungals in this population. PubMed and Embase databases and the references of related publications were searched in March 2012 for clinical trials (<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content>s), retrospective analyses (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s), and case reports (<jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>s) on the use of systemic antifungals for onychomycosis in children (&lt;18\u00a0years). Twenty\u2010six studies (5 <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content>s, 3 <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>s, and 18 <jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>s) were published between 1976 and 2011. Most of these studies reported the use of systemic terbinafine and itraconazole for the treatment of onychomycosis in children. Therapy with systemic antifungals alone in children ages 1 to 17\u00a0years resulted in a complete cure rate of 70.8% (<jats:italic>n\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>151), whereas combined systemic and topical antifungal therapy in one infant and 19 children age 8 and older resulted in a complete cure rate of 80.0% (<jats:italic>n\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>20). The efficacy and safety profiles of terbinafine, itraconazole, griseofulvin, and fluconazole in children were similar to those previously reported for adults. In conclusion, based on the little information available on onychomycosis in children, systemic antifungal therapies in children are safe and cure rates are similar to the rates achieved in adults.<\/jats:p>","DOI":"10.1111\/pde.12048","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T01:49:23Z","timestamp":1356572963000},"page":"294-302","source":"Crossref","is-referenced-by-count":40,"title":["Systemic Antifungals to Treat Onychomycosis in Children: A Systematic Review"],"prefix":"10.1111","volume":"30","author":[{"given":"Aditya K","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Dermatology Department of Medicine University of Toronto Toronto Canada"},{"name":"Clinical Research Mediprobe Research Inc London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Paquet","sequence":"additional","affiliation":[{"name":"Clinical Research Mediprobe Research Inc London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,12,26]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1998.tb01396.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2009.12.006"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2008\/186345","article-title":"Antifungal agents for common paediatric infections","volume":"19","author":"Canadian Paediatric Society","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"e_1_2_6_5_1","unstructured":"Novartis Pharmaceuticals Corporation.Lamisil tablets (terbinafine) label information2011.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020539s021lbl.pdf"},{"key":"e_1_2_6_6_1","unstructured":"Novartis Pharmaceuticals Corporation.Lamisil oral granules (terbinafine) label information2011.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022071s007lbl.pdf"},{"key":"e_1_2_6_7_1","unstructured":"Ortho\u2010McNeil\u2010Janssen Pharmaceuticals.Sporanox capsules (itraconazole) label information2012.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020083s048s049s050lbl.pdf"},{"key":"e_1_2_6_8_1","unstructured":"Centocor Ortho Biotech.Sporanox oral solution (itraconazole) label information2011.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020657s028lbl.pdf"},{"key":"e_1_2_6_9_1","unstructured":"Pfizer.Diflucan tablets (fluconazole) label information2011.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019949s055 019950s059 020090s038lbl.pdf"},{"key":"e_1_2_6_10_1","unstructured":"Novartis Consumer Health.Gris\u2010PEG tablets (griseofulvin ultramicrosize) label information2010.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/050475s054lbl.pdf"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90327-8"},{"key":"e_1_2_6_12_1","first-page":"101","article-title":"Mycoses in children: systemic treatment","volume":"7","author":"Ginter G","year":"1998","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02498.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018256"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb00711.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/000155502762064764"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.154.6.614"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2005.01161.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117520"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1996.tb00732.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01392.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.18221900.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90522-8"},{"key":"e_1_2_6_24_1","first-page":"253","article-title":"Trichophyton rubrum onychomycosis in a 17\u2010year\u2010old girl","volume":"60","author":"Elewski BE","year":"1997","journal-title":"Cutis"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2008.01519.x"},{"key":"e_1_2_6_26_1","first-page":"S629","article-title":"A 14\u2010year\u2010old boy with onychomycosis","volume":"5","author":"Friedlander SF","year":"2005","journal-title":"Adv Stud Med"},{"key":"e_1_2_6_27_1","first-page":"390","article-title":"Recurrent proximal white subungual onychomycosis associated with a defect of the polymorphonuclear chemotaxis","volume":"9","author":"Gianni C","year":"1999","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1995.tb00126.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80215-0"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1998.tb01397.x"},{"key":"e_1_2_6_31_1","first-page":"1034","article-title":"Tinea in tiny tots","volume":"140","author":"Jacobs AH","year":"1986","journal-title":"Am J Dis Child"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.84069"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197608000-00046"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2001.01949.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1997.tb00223.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70025-8"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05728.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.02.038"},{"issue":"4","key":"e_1_2_6_39_1","first-page":"CD004685","article-title":"Systemic antifungal therapy for tinea capitis in children","author":"Gonz\u00e1lez U","year":"2007","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpde.12048","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.12048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T22:00:26Z","timestamp":1698703226000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.12048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,26]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/pde.12048"],"URL":"https:\/\/doi.org\/10.1111\/pde.12048","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,26]]}}}